Lijie W. Wang

General Hospital Of Chinese PLA Fuxing Road 28#
Haidian, 100853, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 37 publications

Safety and efficacy of Cisplatin in combination with Sintilimab and Niraparib in patients with advanced solid tumors: A phase Ib study.

Safety and efficacy of Cisplatin in combination with Sintilimab and Niraparib in patients with advanced solid tumors: A phase Ib study.

Journal: Cancer pathogenesis and therapy

Published: May 08, 2025

Immune Checkpoint Inhibitor Without Pemetrexed for First-line Maintenance Therapy in Advanced Lung Adenocarcinoma: A Real-World Retrospective Study.

Immune Checkpoint Inhibitor Without Pemetrexed for First-line Maintenance Therapy in Advanced Lung Adenocarcinoma: A Real-World Retrospective Study.

Journal: Clinical lung cancer

Published: May 08, 2025

TP63 mediates the generation of tumour-specific chromatin loops that underlie MYC activation in radiation-induced tumorigenesis.

TP63 mediates the generation of tumour-specific chromatin loops that underlie MYC activation in radiation-induced tumorigenesis.

Journal: Nature communications

Published: December 18, 2024

Integrating genomic and pathological characteristics to enhance prognostic precision in advanced NSCLC.

Integrating genomic and pathological characteristics to enhance prognostic precision in advanced NSCLC.

Journal: NPJ precision oncology

Published: August 27, 2024

Efficacy and safety of camrelizumab plus famitinib in patients with previously treated non-small-cell lung cancer: a single-arm, phase II trial.

Efficacy and safety of camrelizumab plus famitinib in patients with previously treated non-small-cell lung cancer: a single-arm, phase II trial.

Journal: Therapeutic advances in medical oncology

Published: August 27, 2024

Treatment strategies with combined agency against severe viral pneumonia in patients with advanced cancer.

Treatment strategies with combined agency against severe viral pneumonia in patients with advanced cancer.

Journal: Journal of translational internal medicine

Published: July 31, 2024

First-line treatment with HDACis plus tislelizumab combined with chemotherapy in advanced NSCLC: a single-arm phase II study.

First-line treatment with HDACis plus tislelizumab combined with chemotherapy in advanced NSCLC: a single-arm phase II study.

Journal: The oncologist

Published: June 14, 2024

The Efficacy of Pemigatinib in Advanced NSCLC With FGFR Aberration: Case Report.

The Efficacy of Pemigatinib in Advanced NSCLC With FGFR Aberration: Case Report.

Journal: Clinical lung cancer

Published: July 18, 2023

Gut mycobiome as a potential non-invasive tool in early detection of lung adenocarcinoma: a cross-sectional study.

Gut mycobiome as a potential non-invasive tool in early detection of lung adenocarcinoma: a cross-sectional study.

Journal: BMC medicine

Published: June 26, 2023

Pralsetinib-associated pneumonia in RET fusion-positive non-small cell lung cancer.

Pralsetinib-associated pneumonia in RET fusion-positive non-small cell lung cancer.

Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

Published: May 21, 2023

Prediction model for hyperprogressive disease in patients with advanced solid tumors received immune-checkpoint inhibitors: a pan-cancer study.

Prediction model for hyperprogressive disease in patients with advanced solid tumors received immune-checkpoint inhibitors: a pan-cancer study.

Journal: Cancer cell international

Published: May 03, 2023

Efficacy and safety of pembrolizumab versus sintilimab treatment in patients with advanced squamous lung cancer: A real-world study in China.

Efficacy and safety of pembrolizumab versus sintilimab treatment in patients with advanced squamous lung cancer: A real-world study in China.

Journal: Frontiers in oncology

Published: January 19, 2023

Showing 1-12 of 37

Last Updated: 09/26/2026